Fradimycin B
CAS: 1429166-72-2
Ref. 3D-EHC16672
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
Fradimycin B is an anticancer drug that belongs to a class of human kinase inhibitors. It has been shown to be effective against a variety of cancer cells, including those resistant to other treatments. Fradimycin B works by inhibiting the activity of kinases, which are proteins that play a key role in cell growth and division. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Fradimycin B has also been found in Chinese medicinal urine and has potential therapeutic applications for the treatment of tumors. Additionally, it has been studied in combination with sertraline as a potential cancer therapy. Overall, Fradimycin B shows promise as a potent inhibitor of cancer cell proliferation and survival.
Propriedades químicas
Consulta técnica sobre: 3D-EHC16672 Fradimycin B
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
